Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy

Area of Science:

• Cardiovascular Biology
• Genetics
• Molecular Medicine

Background:

• Familial hypertrophic cardiomyopathy (FHC) is linked to sarcomeric protein mutations.
• A myosin light chain M149V mutation is associated with human FHC, but mouse models show conflicting results.
• Transgenic (TG) rabbits offer a complementary model to TG mice for studying cardiac disease.

Purpose of the Study:

• To investigate if the M149V mutation in the essential myosin light chain causes FHC in a TG rabbit model.
• To assess the structural and functional impact of the M149V mutation in the rabbit heart.

Main Methods:

• Isolated and sequenced rabbit essential light chain cDNA.
• Introduced the M149V mutation into the cDNA.
• Utilized the beta-myosin heavy chain promoter for cardiac-specific expression in TG rabbits.
• Analyzed TG rabbits at neonatal, juvenile, and adult stages for disease phenotypes.

Main Results:

• Generated multiple TG rabbit lines with varying levels of M149V myosin light chain replacement.
• Observed no discernible structural or functional disease patterns in any TG rabbit cohort.
• The M149V mutation did not induce FHC-like phenotypes in rabbits.

Conclusions:

• The M149V mutation is not causative for FHC when expressed in the rabbit heart.
• TG rabbits expressing the M149V mutation do not develop hypertrophic cardiomyopathy.
• This study highlights the importance of model systems in understanding disease mechanisms.